X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ACTAVIS (US) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ACTAVIS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ACTAVIS
Dec-14
STERLING BIOTECH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1117,478-   
Low Rs310,661-   
Sales per share (Unadj.) Rs26.83,147.4-  
Earnings per share (Unadj.) Rs-15.0-392.8-  
Cash flow per share (Unadj.) Rs-5.5288.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.96,826.5-  
Shares outstanding (eoy) m267.87265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.5 5.8%   
Avg P/E ratio x-0.5-35.8 1.3%  
P/CF ratio (eoy) x-1.348.7 -2.6%  
Price / Book Value ratio x0.12.1 6.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8623,741,152 0.0%   
No. of employees `0001.421.6 6.3%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.338,744.6 13.7%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.0-4,834.9 61.2%   
INCOME DATA
Net Sales Rs m7,181836,882 0.9%  
Other income Rs m43-2,089 -2.0%   
Total revenues Rs m7,223834,794 0.9%   
Gross profit Rs m947107,509 0.9%  
Depreciation Rs m2,543181,216 1.4%   
Interest Rs m4,37726,397 16.6%   
Profit before tax Rs m-5,931-102,192 5.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,496 0.0%   
Tax Rs m-1,924-5,254 36.6%   
Profit after tax Rs m-4,007-104,434 3.8%  
Gross profit margin %13.212.8 102.6%  
Effective tax rate %32.45.1 631.1%   
Net profit margin %-55.8-12.5 447.1%  
BALANCE SHEET DATA
Current assets Rs m14,335440,930 3.3%   
Current liabilities Rs m49,809321,567 15.5%   
Net working cap to sales %-494.014.3 -3,463.7%  
Current ratio x0.31.4 21.0%  
Inventory Days Days40358 695.3%  
Debtors Days Days17166 257.4%  
Net fixed assets Rs m55,432102,192 54.2%   
Share capital Rs m2680-   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7011,815,167 0.8%   
Long term debt Rs m9,478951,183 1.0%   
Total assets Rs m73,9883,326,604 2.2%  
Interest coverage x-0.4-2.9 12.4%   
Debt to equity ratio x0.60.5 123.0%  
Sales to assets ratio x0.10.3 38.6%   
Return on assets %0.5-2.3 -21.4%  
Return on equity %-27.3-5.8 473.7%  
Return on capital %-6.4-3.0 213.4%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719143,709 1.2%  
From Investments Rs m-3,148-344,094 0.9%  
From Financial Activity Rs m1,426193,331 0.7%  
Net Cashflow Rs m-3-7,054 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 64.07 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: ABBOTT INDIA  FDC LTD.  BIOCON LTD  IPCA LABS  PANACEA BIOTECH  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views On News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 23, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS